SimpliFASD
Health & Fitness
Free · Designed for iPad. Not verified for macOS.
With the decision tree, prescribers will be able to identify one of four clusters of symptoms with which to target treatment. "Clusters" include hyperarousal, emotional dysregulation, hyperactivity/neurocognitive, and cognitive inflexibility. Once the primary cluster with the greatest impact on patient functioning is known, then the algorithm decision tree identifies a first-line and second-line medication to prescribe. An adjunct therapy is also given for each cluster. Using the decision tree will help manage FASD/ND-PAE patients improve daily function and reduce unnecessary and unwanted medication. Four to six weeks after using the decision tree, prescribers can complete a brief survey to help evaluate the effectiveness of this first-ever medication decision tree for FASD/ND-PAE patients.
** This app integrates with the Health app **
Ratings & Reviews
- This app hasn’t received enough ratings or reviews to display an overview.
Improvements & bugfixes
The developer, Avicenna Research Inc., indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .
Data Linked to You
The following data may be collected and linked to your identity:
- Contact Info
Data Not Linked to You
The following data may be collected but it is not linked to your identity:
- Diagnostics
Accessibility
The developer has not yet indicated which accessibility features this app supports. Learn More
Information
- Seller
- Avicenna Research Inc.
- Size
- 188.2 MB
- Category
- Health & Fitness
- Compatibility
Requires iOS 13.0 or later.
- iPhone
Requires iOS 13.0 or later. - iPad
Requires iPadOS 13.0 or later. - iPod touch
Requires iOS 13.0 or later. - Mac
Requires macOS 11.0 or later and a Mac with Apple M1 chip or later. - Apple Vision
Requires visionOS 1.0 or later.
- iPhone
- Languages
English and 12 more
- English, Catalan, Dutch, French, German, Italian, Persian, Slovenian, Spanish, Thai, Urdu, Vietnamese, Zulu
- Age Rating
4+
- 4+
- Copyright
- © Avicenna Research, Inc.